Pathogenesis of keratoconus: NRF2-antioxidant, extracellular matrix and cellular dysfunctions.
- Authors
- Type
- Published Article
- Journal
- Experimental Eye Research
- Publisher
- Elsevier
- Publication Date
- Apr 03, 2022
- Volume
- 219
- Pages
- 109062–109062
- Identifiers
- DOI: 10.1016/j.exer.2022.109062
- PMID: 35385756
- Source
- Medline
- Keywords
- Language
- English
- License
- Unknown
Abstract
Keratoconus (KC) is a degenerative disease associated with cell and extracellular matrix (ECM) loss that causes gradual thinning and steepening of the cornea and loss of vision. Collagen cross linking with ultraviolet light treatment can strengthen the ECM and delay weakening of the cornea, but severe cases require corneal transplantation. KC is multifactorial and multigenic, but its pathophysiology is still an enigma. Multiple approaches are being pursued to elucidate the molecular changes that underlie the corneal phenotype to identify relevant genes for tailored candidate searches and to develop potential biomarkers and targets for therapeutic interventions. Recent proteomic and transcriptomic studies suggest dysregulations in oxidative stress, NRF2-regulated antioxidant programs, WNT-signaling, TGF-β, ECM and matrix metalloproteinases. This review aims to provide a broad update on the transcriptomic and proteomic studies of KC with a focus on findings that relate to oxidative stress, and dysregulations in cellular and extracellular matrix functions. Copyright © 2022. Published by Elsevier Ltd.